STOCK TITAN

Armistice Capital (VSEE) reports 9.99% ownership; Steven Boyd co-filer

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

VSee Health, Inc. ownership disclosure: Armistice Capital, LLC and Steven Boyd report shared beneficial ownership of 1,889,308 shares of Common Stock, representing 9.99% of the class as of 12/31/2025.

The filing states Armistice Capital is investment manager of the Master Fund, which directly holds the shares, and that Mr. Boyd, as managing member, may be deemed to beneficially own those shares. The Master Fund disclaims beneficial ownership by virtue of its Investment Management Agreement with Armistice Capital. Signatures are dated 02/17/2026.

Positive

  • None.

Negative

  • None.

Insights

Reported 9.99% stake is a large disclosed passive holding under Schedule 13G.

Armistice Capital and Steven Boyd report shared beneficial ownership of 1,889,308 shares, stated as 9.99% of the class as of 12/31/2025. The filing follows the co-filing/joint statement format and identifies the Master Fund as the direct holder.

Material dependencies include the Investment Management Agreement that the filing cites; the Master Fund’s disclaimer of beneficial ownership is a contractual attribution point. Subsequent amendments or changes in holdings would appear in later Schedule 13 filings.

Disclosure reflects voting and dispositive power exercised by the investment manager, not necessarily direct economic ownership by the reporting persons.

The filing states Armistice Capital ‘‘exercises voting and investment power’’ over securities held by Armistice Capital Master Fund Ltd., and Mr. Boyd may be deemed beneficial owner as managing member. The Master Fund is identified as the direct holder entitled to dividends or proceeds.

Cash-flow treatment and any sale intentions are not included in the excerpt; future Schedule 13D/13G amendments would disclose changes in intent or percent ownership.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Armistice Capital, LLC
Signature:/s/ Steven Boyd
Name/Title:Steven Boyd - Managing Member
Date:02/17/2026
Steven Boyd
Signature:/s/ Steven Boyd
Name/Title:Steven Boyd
Date:02/17/2026
Exhibit Information

JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate. Dated: February 17, 2026 Armistice Capital, LLC By: /s/ Steven Boyd Steven Boyd - Managing Member Steven Boyd By: /s/ Steven Boyd

FAQ

What stake does Armistice Capital report in VSEE?

Armistice Capital and Steven Boyd report beneficial ownership of 1,889,308 shares, equal to 9.99%. The filing states this figure is based on issuer information and reflects shared voting and dispositive power as of 12/31/2025.

Who is the direct holder of the VSEE shares reported by Armistice Capital?

The direct holder is Armistice Capital Master Fund Ltd., the Master Fund. Armistice Capital is the Master Fund’s investment manager and exercises voting and investment power over the reported shares.

Does the filing state Mr. Steven Boyd personally owns the shares?

The filing states Mr. Boyd, as managing member of Armistice Capital, may be deemed to beneficially own the shares. It does not assert sole direct ownership; the Master Fund is the direct holder.

What voting and dispositive powers are reported?

The reporting persons disclose 0 shares of sole voting or dispositive power and 1,889,308 shares of shared voting and shared dispositive power for VSEE Common Stock.

When was the Schedule 13G signed for this disclosure?

The signatures on the filing are dated 02/17/2026, reflecting the reporting persons’ certification of the information in the Schedule 13G concerning holdings as of 12/31/2025.
VSee Health, Inc.

NASDAQ:VSEE

VSEE Rankings

VSEE Latest News

VSEE Latest SEC Filings

VSEE Stock Data

13.32M
32.98M
Health Information Services
Services-health Services
Link
United States
BOCA RATON